New 2026 Cholesterol Guidelines: ApoB and Lp(a) Explained
- Sean Hashmi
- 2 days ago
- 3 min read
The short answer
In March 2026, the American College of Cardiology, the American Heart Association, and ten other organizations released a dyslipidemia guideline that retires the 2018 cholesterol rulebook, brings back hard LDL targets set by your risk, and moves two often-skipped numbers to the center. The first is ApoB, which counts the artery-damaging particles rather than the cholesterol they carry, so a normal LDL can still hide real risk in metabolic syndrome, prediabetes, or high triglycerides. The second is lipoprotein(a), or Lp(a), a mostly genetic particle that affects roughly one in five people, and the guideline now says every adult should measure it once. Lowering LDL still saves lives, and in clinic I regularly see someone relieved by a normal cholesterol whose particle count turns out high, so the practical move is to check whether ApoB and Lp(a) are even on your labs.
What we cover
Why the 2026 ACC/AHA guideline restored hard LDL targets set by your risk band (Circulation, 2026): https://doi.org/10.1161/CIR.0000000000001423
The Lancet 2010 evidence that each drop of about 39 mg/dL in LDL cut major vascular events by roughly a fifth (Lancet, 2010): https://doi.org/10.1016/S0140-6736(10)61350-5
Why ApoB counts particles and is a more accurate risk marker than LDL cholesterol (Journal of the American Heart Association, 2022): https://doi.org/10.1161/JAHA.122.025858
How often ApoB and LDL disagree, and who that hits hardest (International Journal of Cardiology, 2023): https://doi.org/10.1016/j.ijcard.2023.131150
The honest read on statin muscle symptoms from blinded trials
What Lp(a) is, why diet and exercise barely move it, and why one measurement is enough
What to do if your Lp(a) is high, including telling your blood relatives
Timestamps
00:00 What the 2026 guidelines changed
01:00 Why hard LDL targets are back
02:47 Are statins a scam? The evidence
04:44 Why your LDL target depends on your risk
06:17 ApoB, the particle count your panel skips
08:53 Lp(a), the one-time test every adult needs
12:10 Your one move this week
References
The 2026 ACC/AHA multisociety guideline on the management of dyslipidemia. A clinical practice guideline that replaces the 2018 blood cholesterol guideline, restores explicit LDL targets by risk, and formally addresses triglycerides and lipoprotein(a). Circulation, 2026. https://doi.org/10.1161/CIR.0000000000001423
The Cholesterol Treatment Trialists' meta-analysis pooled 170,000 people across 26 randomized trials and found each drop of about 39 mg/dL in LDL cut major vascular events by roughly a fifth, with benefit even when starting LDL was already low. Meta-analysis of randomized trials. Lancet, 2010. https://doi.org/10.1016/S0140-6736(10)61350-5
Glavinovic and colleagues laid out the physiology of why ApoB, the particle count, is a more accurate marker of cardiovascular risk than LDL cholesterol or non-HDL cholesterol. Physiology review. Journal of the American Heart Association, 2022. https://doi.org/10.1161/JAHA.122.025858
Solnica and colleagues measured ApoB, LDL, and non-HDL cholesterol in the NATPOL 2011 survey and found the two disagree often, with high-ApoB, low-LDL people carrying features of metabolic syndrome. Observational population survey, shows association, not causation. International Journal of Cardiology, 2023. https://doi.org/10.1016/j.ijcard.2023.131150
When to see a doctor
Ask your clinician to interpret your lipid panel and to add ApoB and a one-time Lp(a) if they are not already there, especially with metabolic syndrome, prediabetes, high triglycerides, chronic kidney disease, or a family history of early heart attacks.
Get my free metabolic health guides: https://guides.selfprinciple.org/metabolic
This content is for educational purposes only and is not medical advice. Always consult your healthcare provider for individual care. The views expressed are Dr. Hashmi's own and do not represent his employer.
Comments